Polar Securities »

Cytokinetics shares owned by Polar Securities

Quarter-by-quarter ownership of Cytokinetics shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Polar Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 7.5M 1.76
2023-09-30 $25M 29M 0.85

More positions owned by Polar Securities

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Sprott Asset Management Physical Gold Tr (PHYS)
Interdigital Note 3.500% 6/0 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
NVIDIA Corporation (NVDA)
Home Depot (HD)
Axon Enterprise Note 0.500%12/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Apple (AAPL)
Verona Pharma Sponsored Ads (VRNA)
Broadcom (AVGO)
Itron Note 1.375% 7/1 (Principal)
Tesla Motors (TSLA)
Arista Networks Com Shs (ANET)

View all positions for Polar Securities

Top funds holding Cytokinetics

FMR
Balyasny Asset Management
Wellington Management Company
Lazard Asset Management
Goldman Sachs Group
Capstone Investment Advisors
Leucadia National Corporation
Wells Fargo & Company
AXA Investment Managers
Bnp Paribas Investment Partners
Gabelli Funds
Jpmorgan Chase & Co
Jane Street
Shenkman Capital Management
Bank of New York Mellon

View all funds holding Cytokinetics